- Home
- ONC vs RJF Comparison
ONC vs RJF Comparison
Compare ONC & RJF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONC
- RJF
- Stock Information
- Founded
- ONC 2010
- RJF 1962
- Country
- ONC Switzerland
- RJF United States
- Employees
- ONC N/A
- RJF N/A
- Industry
- ONC Biotechnology: Pharmaceutical Preparations
- RJF Investment Bankers/Brokers/Service
- Sector
- ONC Health Care
- RJF Finance
- Exchange
- ONC Nasdaq
- RJF Nasdaq
- Market Cap
- ONC 26.9B
- RJF 30.1B
- IPO Year
- ONC N/A
- RJF N/A
- Fundamental
- Price
- ONC $250.30
- RJF $158.89
- Analyst Decision
- ONC Strong Buy
- RJF Buy
- Analyst Count
- ONC 9
- RJF 10
- Target Price
- ONC $325.56
- RJF $164.20
- AVG Volume (30 Days)
- ONC 345.1K
- RJF 1.1M
- Earning Date
- ONC 08-06-2025
- RJF 07-23-2025
- Dividend Yield
- ONC N/A
- RJF 1.26%
- EPS Growth
- ONC N/A
- RJF 25.52
- EPS
- ONC N/A
- RJF 10.38
- Revenue
- ONC $4,175,868,000.00
- RJF $13,567,000,000.00
- Revenue This Year
- ONC $869.15
- RJF $9.13
- Revenue Next Year
- ONC $19.07
- RJF $7.17
- P/E Ratio
- ONC N/A
- RJF $15.27
- Revenue Growth
- ONC 51.16
- RJF 13.41
- 52 Week Low
- ONC $146.21
- RJF $104.24
- 52 Week High
- ONC $287.88
- RJF $174.32
- Technical
- Relative Strength Index (RSI)
- ONC N/A
- RJF 64.70
- Support Level
- ONC N/A
- RJF $156.79
- Resistance Level
- ONC N/A
- RJF $161.00
- Average True Range (ATR)
- ONC 0.00
- RJF 2.78
- MACD
- ONC 0.00
- RJF 0.48
- Stochastic Oscillator
- ONC 0.00
- RJF 81.40
About ONC BeiGene Ltd. American Depositary Shares
Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeiGene is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeiGene runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeiGene's revenue.
About RJF Raymond James Financial Inc.
Raymond James Financial is a financial holding company whose major operations include wealth management, investment banking, asset management, and commercial banking. The company supports more than 8,000 employee and independent contractor financial advisors across the United States, Canada, and the United Kingdom with over $1.5 trillion of assets under administration as of September 2024. Approximately 90% of the company's revenue is from the US and 70% is from the company's wealth-management segment.